Abstract:OBJECTIVE:To explore the effects of transcription factor SOX9 on chondrogenic differentiation potential of human umbilical cord mesenchymal stem cells (hUC-MSCs).METHODS:hUC-MSCs were harvested from human umbilical cord and their phenotypic characteristics identified by flow cytometry. To confirm their multipotency, hUC-MSCs were induced to differentiate toward adiposity and osteogenesis. After transfection with the packaging lentivirus vectors containing SOX9 in vitro, the expression of green fluorescent protein (GFP) and the efficiency of transfection were detected by fluorescence microscopy. Their cellular proliferation capacity was detected by thiazolyl blue tetrazolium bromide (MTT) assay.hUC-MSCs modified with SOX9 were seeded into monolayer and cultured for 21 days in a defined, serum-free medium supplemented with transforming growth factor (TGF)-β1. The untransduced cells or those transduced with GFP served as the controls. Morphologic changes of hUC-MSCs were observed daily and their chondrogenic differentiation was evaluated by reverse transcription-polymerase chain reaction (RT-PCR), Western blot, and immunofluorescent staining. And the accumulation of sulfated glycosaminoglycans was detected by Alcian blue staining. Meanwhile, the expressions of collagen I, X and cell adhesion molecule N-cadherin were assayed.RESULTS:The hUC-MSCs isolated from human umbilical cord stromas exhibited fibroblastic morphology and they were positive for CD29 (95.9%), CD44 (96.5%), CD90 (98.9%), CD105 (94.3%) and negative for hematopoietic stem cells surface markers CD34 (3.0%) and CD45 (2.6%). At Day 21, hUC-MSCs differentiated toward adiposity and osteogenesis. Both oil red O and alkaline phosphatase stains were intensely positive and it confirmed the multilineage potential of hUC-MSCs. An intense expression of GFP was observed under flourescence microscope and the transfection efficiency of cells with Lenti-GFP-SOX9 or Lenti-GFP was more than 90% respectively. SOX9 gene was over-expressed in hUC-MSCs at 48 h post-transduction. The proliferation of hUC-MSCs had no significant effect after the transfection of lentivirus vectors (P > 0.05). In vitro high-density monolayer culture of these SOX9-transfected hUC-MSCs demonstrated that spontaneous cell aggregation appeared at Day 14 of culturing and subsequently generated large cartilage nodules. However there was no phenomenon of cell aggregation occurring in the cells transducted by Lenti-GFP or untransduced vectors. The expressions of collagen II and Aggrecan were higher in SOX9 transducted cells than those in the controls. Alcian blue staining also showed abundant accumulation of sulfated glycosaminoglycans in the SOX9-induced cartilage nodules. The expression of collagen I had no difference in all groups and collagen X was inhibited in SOX9 transduced cells. N-cadherin was strongly up-regulated by SOX9 and might result in cellular aggregation and formation of large cartilage nodules.CONCLUSION:SOX9 may enhance the chondrogenic differentiation potential of human umbilical cord mesenchymal stem cells through cellular aggregation.

Sox9 Potentiates BMP2-Induced Chondrogenic Differentiation and Inhibits BMP2-Induced Osteogenic Differentiation

Co-expression of BMP2 and Sox9 Promotes Chondrogenic Differentiation of Mesenchymal Stem Cells in Vitro

Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter.

Sox9 Inhibits Wnt Signaling by Promoting Beta-Catenin Phosphorylation in the Nucleus

BMP2 induces chondrogenic differentiation, osteogenic differentiation and endochondral ossification in stem cells

The role of Sox9 in collagen hydrogel-mediated chondrogenic differentiation of adult mesenchymal stem cells (MSCs)

Effects of Cartilage Oligomeric Matrix Protein on Bone Morphogenetic Protein‐2‐induced Differentiation of Mesenchymal Stem Cells

Bone Morphogenetic Protein-2 Induces Chromatin Remodeling and Modification at the Proximal Promoter of Sox9 Gene.

HIF-1α as a Regulator of BMP2-Induced Chondrogenic Differentiation, Osteogenic Differentiation, and Endochondral Ossification in Stem Cells.

Characterization of Sox9-overexpressing Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells-Based Engineered Cartilage Both in Vitro and in Vivo.

Delivery of the Sox9 Gene Promotes Chondrogenic Differentiation of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in an in Vitro Model.

Sonic Hedgehog potentiates BMP9-induced osteogenic differentiation of mesenchymal stem cells

Co-overexpression of TGF-β and SOX9 Via Raav Gene Transfer Modulates the Metabolic and Chondrogenic Activities of Human Bone Marrow-Derived Mesenchymal Stem Cells.

Synergistic Effects of BMP9 and Mir-548D-5p on Promoting Osteogenic Differentiation of Mesenchymal Stem Cells.

Increased Expression of Sox9 During Balance of BMSCs/Chondrocyte Bricks in Platelet-Rich Plasma Promotes Construction of a Stable 3-D Chondrogenesis Microenvironment for BMSCs

Assessment of the expression profile of SRY-type high-mobility-group box-9 during chondrogenesis of mice and the effects of transfection of recombinant rat sty-type high-mobility-group box-9 on mice mesenchymal stem cells in vitro

Matricellular Protein SMOC2 Potentiates BMP9-Induced Osteogenic Differentiation in Mesenchymal Stem Cells through the Enhancement of FAK/PI3K/AKT Signaling

[SOX9 Enhanced Chondrogenic Differentiation Potential of Human Umbilical Cord Mesenchymal Stem Cells Through Cellular Aggregation].

Lysine 68 Methylation‐Dependent SOX9 Stability Control Modulates Chondrogenic Differentiation in Dental Pulp Stem Cells

The SIRT1 activator SRT2104 promotes BMP9-induced osteogenic and angiogenic differentiation in mesenchymal stem cells

Synergistic Effect of QNZ, an Inhibitor of NF-kappa B Signaling, and Bone Morphogenetic Protein 2 on Osteogenic Differentiation in Mesenchymal Stem Cells through Fibroblast-Induced Yes-Associated Protein Activation